QQ客服 官方微博 反馈留言

	Epidermal growth factor receptor T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study.
	Zhang, SR; Zhu, LC; Xia, B; Chen, EG; Zhao, Q; Zhang, XC; Chen, XQ; Chen, XF; Ma, SL
刊名	CANCER COMMUNICATIONS
	2018
卷号	Vol.38
关键词	Epidermal growth factor receptor Failure sites Non-small cell lung cancer T790M ctDNA
ISSN号	2523-3548;2523-3548
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5462158
专题	湖南大学
作者单位	1.Nanjing Med Univ, Hangzhou Peoples Hosp 1, Ctr Translat Med, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China 2.Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Oncol, Hangzhou 310006, Zhejiang, Peoples R China 3.Hangzhou Canc Hosp, Dept Oncol, Hangzhou 310000, Zhejiang, Peoples R China 4.Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Resp, Hangzhou 310020, Zhejiang, Peoples R China 5.Zhejiang Univ, Affiliated Hosp 1, Dept Oncol, Hangzhou 310006, Zhejiang, Peoples R China 6.City Hope Natl Med Ctr, Dept Canc Genet & Epigenet, Duarte, CA 91010 USA
推荐引用方式 GB/T 7714	Zhang, SR,Zhu, LC,Xia, B,et al. Epidermal growth factor receptor T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study.[J]. CANCER COMMUNICATIONS,2018,Vol.38.
APA	Zhang, SR.,Zhu, LC.,Xia, B.,Chen, EG.,Zhao, Q.,...&Ma, SL.(2018).Epidermal growth factor receptor T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study..CANCER COMMUNICATIONS,Vol.38.
MLA	Zhang, SR,et al."Epidermal growth factor receptor T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study.".CANCER COMMUNICATIONS Vol.38(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。